Ellman International Announces Executive Team Hire Frank D'Amelio joins Ellman International as Chief Operating Officer, Executive Vice President
OCEANSIDE, N.Y., Sept. 1 /PRNewswire/ -- Ellman International, Inc., a New York based developer, manufacturer and marketer of RF devices for surgical and aesthetic procedures, announced that Frank D. D'Amelio will join its executive team in the position of Chief Operating Officer (COO), Executive Vice President. "We are proud to welcome Mr. D'Amelio, a senior medical device professional who will help guide the company's continued growth," said Chief Executive Officer Rick Epstein.
Innovation and aggressive new product development will mark the next phase for Pelleve and Ellman International. "Frank's extensive experience in developing strong global strategic alliances will be invaluable as we seek new breakthrough technologies to reinforce our versatility in surgical and non-surgical aesthetic systems," said Mr. Epstein.
D'Amelio brings over 25 years of executive experience in the areas of worldwide business development, manufacturing and operations, and the strategic research and development portfolio management. Most recently, he served as the President of LTC Technologies, a bipolar tissue sealing and welding company and was the former Chief Technology Officer of Gyrus/ACMI, a leading global medical visualization and surgical energy company. At Gyrus/ACMI, Mr. D'Amelio developed and launched numerous endoscopic and electrosurgical systems for the GI, general surgery, urology and gynecology markets and formed a number of significant strategic alliances with other medical device companies. He is a named inventor of approximately 40 worldwide issued or pending patents.
"As we plan for continued growth, we need strong, globally experienced medical device leaders. Frank will complement our already diverse & dynamic sales and marketing leadership teams," added Epstein.
"Ellman International and Pelleve are well positioned and offer a great platform for both internal development of new leading edge products and properly structured strategic alliances. I look forward to working with the marketing, sales and financial teams at Ellman to bring these products and services to the market," said D'Amelio.
About Ellman International
Established in 1959, Ellman International (Oceanside, New York) is a privately held developer, manufacturer and marketer of medical devices for surgical procedures requiring cutting, coagulating, and tissue ablation. A trusted leader in high frequency radiowave energy sources, Ellman's advanced technologies offer unique versatility and precision to the surgical and aesthetic markets. In 2008, Baird Capital Partners and an investment group, which includes Ellman's senior executives, acquired Ellman.
The company's proven product platform includes the Surgitron® Dual RF™ S5, which provides patented 4.0 MHz energy delivery for maximum control in precision cutting, with more versatility than other technologies in the office and clinic environments. The Dual RF™ S5 also powers the Pelleve™ Wrinkle Reduction System, the innovative, FDA-cleared skin tightening system for nonablative wrinkle treatment. Pelleve™ safely treats facial wrinkles without surgery by improving skin firmness for a naturally refreshed appearance. For more information, please visit www.ellman.com and www.pelleve.com.
SOURCE Ellman International, Inc.